We are a team of 75 artists, designers, technologists and real estate professionals, spread across three continents, who passionately create the world’s leading 3D visualization and digital tools for marketing new developments. Our incredible products have helped developers and sales agents lease over $100 Billion of new development real estate worldwide.
At Evolution, we bring a deep cross-disciplinary knowledge and experience to the table for our clients. Our success resides not just in our extensive real estate knowledge – having executed hundreds of millions of transactions ourselves, and having worked with the leading projects around the world – but decades of experience designing and building leading technologies across five industries.
Work with us to create transcendent renderings and animations, the mobile sales presentation and immersive sales gallery of your dreams, the worlds highest quality 3D interactive, cutting-edge virtual reality experiences and much more.
Over 25 years, Jonathan has built successful products and businesses in technology, financial services, pharmaceuticals, marketing, publishing and alternative energy at organizations like NASA, Intel, Goldman Sachs, Precision Therapies and Eli Lilly.
Before co-founding Evolution Ventures, Jonathan worked as Vice President of Strategic Planning at Woolbright Development, where he was responsible for raising $250 million in institutional capital and designing technology solutions to improve leasing, acquisitions and operations. At Goldman Sachs, Jonathan designed and issued new securities and derivatives to enable REITs and corporations to more efficiently access capital. His other experiences have ranged from salvaging a $1 Billion osteoporosis drug at Eli Lilly to creating a market-leading online research and branding firm, LucidView, which he sold to Jungle Media. Jonathan holds a BS in Computer Science from MIT and an MBA from The Wharton School at the University of Pennsylvania. He is a licensed real estate sales associate in the State of Florida.